Dogwood Therapeutics, Inc. (DWTX)
1.69
-0.03
(-1.74%)
USD |
NASDAQ |
Sep 18, 16:00
1.70
+0.01
(+0.59%)
After-Hours: 20:00
Dogwood Therapeutics Total Assets (Quarterly) : 80.50M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.50M |
| March 31, 2026 | 95.21M |
| December 31, 2025 | 90.66M |
| September 30, 2025 | 91.99M |
| June 30, 2025 | 96.69M |
| March 31, 2025 | 96.98M |
| December 31, 2024 | 101.21M |
| September 30, 2024 | 2.283M |
| June 30, 2024 | 3.636M |
| March 31, 2024 | 3.225M |
| December 31, 2023 | 4.165M |
| September 30, 2023 | 5.249M |
| June 30, 2023 | 5.212M |
| Date | Value |
|---|---|
| March 31, 2023 | 6.521M |
| December 31, 2022 | 8.370M |
| September 30, 2022 | 10.86M |
| June 30, 2022 | 9.040M |
| March 31, 2022 | 12.55M |
| December 31, 2021 | 15.78M |
| September 30, 2021 | 20.11M |
| June 30, 2021 | 23.76M |
| March 31, 2021 | 28.27M |
| December 31, 2020 | 31.47M |
| September 30, 2020 | 0.7854M |
| June 30, 2020 | 1.272M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.13M |
| Shareholders Equity (Quarterly) | 68.37M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 3.894 |
| Net Debt Paydown Yield | 27.97% |